111 related articles for article (PubMed ID: 11760371)
1. Prolonged interferon treatment after combination interferon and ribavirin therapy in patients with chronic hepatitis C: a clinical trial of interferon relapsers and non-responders.
Kao JH; Lai MY; Chen PJ; Cheng YM; Chen DS
J Formos Med Assoc; 2001 Oct; 100(10):662-7. PubMed ID: 11760371
[TBL] [Abstract][Full Text] [Related]
2. Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders: Italian experience.
Brillanti S; Miglioli M; Barbara L
J Hepatol; 1995; 23 Suppl 2():13-5; discussion 15-6. PubMed ID: 8720288
[TBL] [Abstract][Full Text] [Related]
3. Retreatment of non-responder or relapser chronic hepatitis C patients with interferon plus ribavirin vs interferon alone.
Milella M; Santantonio T; Pietromatera G; Maselli R; Casalino C; Mariano N; Genchi C; Pastore G
Ital J Gastroenterol Hepatol; 1999 Apr; 31(3):211-5. PubMed ID: 10379482
[TBL] [Abstract][Full Text] [Related]
4. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin.
Ahmad J; Dodson SF; Demetris AJ; Fung JJ; Shakil AO
Liver Transpl; 2001 Oct; 7(10):863-9. PubMed ID: 11679984
[TBL] [Abstract][Full Text] [Related]
5. Combination of "low-dose" ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected non-responders and relapsers after interferon alfa-2a monotherapy.
Wietzkebetaraun P; Meier V; Braun F; Ramadori G
World J Gastroenterol; 2001 Apr; 7(2):222-7. PubMed ID: 11819764
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trial of interferon gamma versus amantadine in combination with interferon alpha and ribavirin for hepatitis C genotype 3 non-responders and relapsers.
Abbas Z; Raza S; Hamid S; Jafri W
J Pak Med Assoc; 2012 Apr; 62(4):338-43. PubMed ID: 22755276
[TBL] [Abstract][Full Text] [Related]
7. The pattern of response to interferon alpha (alpha-IFN) predicts sustained response to a 6-month alpha-IFN and ribavirin retreatment for chronic hepatitis C. TVVH Study Group.
Cavalletto L; Chemello L; Donada C; Casarin P; Belussi F; Bernardinello E; Marino F; Pontisso P; Gatta A; Alberti A
J Hepatol; 2000 Jul; 33(1):128-34. PubMed ID: 10905596
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with interferon-alpha and ribavirin in patients with dual hepatitis B and hepatitis C virus infection.
Hung CH; Lee CM; Lu SN; Wang JH; Tung HD; Chen CH; Changchien CS
J Gastroenterol Hepatol; 2005 May; 20(5):727-32. PubMed ID: 15853986
[TBL] [Abstract][Full Text] [Related]
9. Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial.
Sostegni R; Ghisetti V; Pittaluga F; Marchiaro G; Rocca G; Borghesio E; Rizzetto M; Saracco G
Hepatology; 1998 Aug; 28(2):341-6. PubMed ID: 9695995
[TBL] [Abstract][Full Text] [Related]
10. Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis C.
August-Jörg BS; Borovicka J; Dufour JF; Gonvers JJ; Henz S; Hermann R; Meyenberger C; Weitz M; Renner EL;
Swiss Med Wkly; 2003 Aug; 133(33-34):455-60. PubMed ID: 14625812
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C in adults and adolescents with hemophilia: a randomized, controlled trial of interferon alfa-2b and ribavirin.
Fried MW; Peter J; Hoots K; Gaglio PJ; Talbut D; Davis PC; Key NS; White GC; Lindblad L; Rickles FR; Abshire TC
Hepatology; 2002 Oct; 36(4 Pt 1):967-72. PubMed ID: 12297845
[TBL] [Abstract][Full Text] [Related]
12. Interferon-alpha2a/ribaviran versus interferon-alpha2a alone for the retreatment of hepatitis C patients who relapse after a standard course of interferon.
Chapman BA; Stace NH; Edgar CL; Bartlett SE; Frampton CM; Scahill SL; Jennings LC
N Z Med J; 2001 Mar; 114(1128):103-4. PubMed ID: 11346153
[TBL] [Abstract][Full Text] [Related]
13. Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantation.
Giostra E; Kullak-Ublick GA; Keller W; Fried R; Vanlemmens C; Kraehenbuhl S; Locher S; Egger HP; Clavien PA; Hadengue A; Mentha G; Morel P; Negro F
Transpl Int; 2004 May; 17(4):169-76. PubMed ID: 15060764
[TBL] [Abstract][Full Text] [Related]
14. Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group.
Keeffe EB; Hollinger FB
Hepatology; 1997 Sep; 26(3 Suppl 1):101S-107S. PubMed ID: 9305673
[TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha plus ribavirin for 12 months increases the sustained response rates in chronic hepatitis C relapsers.
Moreno-Monteagudo JA; Castro A; De Pedro A; Lorenzo JA; Fernández-Bermejo M; Lopez S; García-Buey L; Borque MJ; Pedreira JD; Moreno-Otero R
Aliment Pharmacol Ther; 2002 Feb; 16(2):243-9. PubMed ID: 11860407
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C.
Shakil AO; McGuire B; Crippin J; Teperman L; Demetris AJ; Conjeevaram H; Gish R; Kwo P; Balan V; Wright TL; Brass C; Rakela J
Hepatology; 2002 Nov; 36(5):1253-8. PubMed ID: 12395337
[TBL] [Abstract][Full Text] [Related]
17. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.
Bizollon T; Palazzo U; Ducerf C; Chevallier M; Elliott M; Baulieux J; Pouyet M; Trepo C
Hepatology; 1997 Aug; 26(2):500-4. PubMed ID: 9252166
[TBL] [Abstract][Full Text] [Related]
18. Impact of high-dose interferon induction and ribavirin therapy in patients with chronic hepatitis C relapsing after or not responding to interferon monotherapy.
Steindl-Munda P; Ferenci P; Brunner H; Nachbaur K; Datz C; Gschwantler M; Hofer H; Stauber R; Hackl F; Jessner W; Rosenbeiger M; Gangl A; Vogel W;
Liver Int; 2003 Aug; 23(4):269-75. PubMed ID: 12895267
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C.
Lai MY; Kao JH; Yang PM; Wang JT; Chen PJ; Chan KW; Chu JS; Chen DS
Gastroenterology; 1996 Nov; 111(5):1307-12. PubMed ID: 8898645
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with ribavirin and alpha interferon for the treatment of chronic hepatitis C refractory to interferon.
Cozzolongo R; Cuppone R; Giannuzzi V; Amati L; Caradonna L; Tamborrino V; Jirillo E; Manghisi OG
Aliment Pharmacol Ther; 2001 Jan; 15(1):129-35. PubMed ID: 11136286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
